Opinion|Videos|March 24, 2025

Risk Score Stability and Post Lenvatinib Plus Pembrolizumab Treatment Selection in RCC

Experts discuss risk score stability and post lenvatinib plus pembrolizumab treatment selection in renal cell carcinoma.


Latest CME